• RI - Unifesp
    • Documentos
    • Tutoriais
    • Perguntas frequentes
    • Atendimento
    • Equipe
    • português (Brasil)
    • English
    • español
  • Sobre
    • RI Unifesp
    • Documentos
    • Tutoriais
    • Perguntas frequentes
    • Atendimento
    • Equipe
  • español 
    • português (Brasil)
    • English
    • español
    • português (Brasil)
    • English
    • español
  • Login
Ver ítem 
  •   Repositorio Institucional UNIFESP
  • UNIFESP
  • Unifesp - Em verificação
  • Em verificação - Geral
  • Ver ítem
  •   Repositorio Institucional UNIFESP
  • UNIFESP
  • Unifesp - Em verificação
  • Em verificação - Geral
  • Ver ítem
JavaScript is disabled for your browser. Some features of this site may not work without it.

P-Glycoprotein Expression, Tumor Weight, Age, and Relapse in Patients with Stage I and II Favorable-Histology Wilms' Tumor

Thumbnail
Fecha
2011-04-01
Autor
Plaza Teixeira, Roberto Augusto
Odone-Filho, Vicente
Camargo, Beatriz de
Zerbini, Maria Claudia
Fillipi, Renne
Alencar, Arlaine
Cristofani, Lilian
Tipo
Artigo
ISSN
0888-0018
Es parte de
Pediatric Hematology and Oncology
DOI
10.3109/08880018.2010.533250
Metadatos
Mostrar el registro completo del ítem
Resumen
Fifteen percent of patients with Wilms'' tumor (WT) experience relapse. It has been suggested that weight and age may affect the chances of relapse. Few studies have investigated the role, if any, between P-glycoprotein (P-gp) and relapse. the authors assessed the prognostic value of tumor weight and age at diagnosis and asked whether some other potential biological markers, specifically P-gp protein expression, had a prognostic value in favorable-histology WT. No association between age and relapse could be found. Patients with tumor weight >= a parts per thousand yen550 g were 6 times more likely to relapse, whereas P-gp expression was positive in 18/40 (45%%) of the patients, of which 10/12 (83.3%%) relapsed and 8/28 (28.6%%) did not. Further studies are necessary to elucidate whether or not P-gp is related to relapse in patients with histologically favorable Wilms'' tumor. If confirmed, the protein may be used in the future as a target for new drugs and treatments for this group of patients.</.
Cita
Pediatric Hematology and Oncology. London: Informa Healthcare, v. 28, n. 3, p. 194-202, 2011.
Palabras clave
P-glycoprotein
prognosis
recurrence
tumor weight
Wilms' tumor
URI
http://repositorio.unifesp.br/handle/11600/33629
Colecciones
  • Em verificação - Geral [7511]

DSpace software copyright © 2002-2016  DuraSpace
Contacto
Theme by 
Atmire NV
 

 

Listar

Todo repositorioComunidades & coleccionesPor fecha de publicaciónAutoresTítulosMateriasPor fecha de envíoEsta colecciónPor fecha de publicaciónAutoresTítulosMateriasPor fecha de envío

Mi cuenta

Acceder

Estadísticas

Ver Estadísticas de uso

DSpace software copyright © 2002-2016  DuraSpace
Contacto
Theme by 
Atmire NV